NDC 69097-398 – Paclitaxel protein-bound particles
Paclitaxel 100 mg/20mL · Injection, Powder, Lyophilized, For Suspension · Intravenous
Product NDC69097-398
Product details
- Brand name
- Paclitaxel protein-bound particles
- Generic name
- Paclitaxel protein-bound particles
- Labeler
- Cipla USA Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Suspension
- Route
- Intravenous
- Marketing category
- ANDA · ANDA209657
- Marketed since
- April 15, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Microtubule Inhibitor
Active ingredients
- Paclitaxel 100 mg/20mL
Uses, dosage, side effects and warnings for Paclitaxel protein-bound particles →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 69097-398-78 | 1 VIAL, SINGLE-DOSE in 1 CARTON (69097-398-78) / 20 mL in 1 VIAL, SINGLE-DOSE | Apr 15, 2025 |